Variant report
Variant | esv3417177 |
---|---|
Chromosome Location | chr4:92360440-92385422 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000212195 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs554570904 | chr4:92369675-92369676 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs62309588 | chr4:92369698-92369699 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs554259062 | chr4:92369735-92369736 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs186385773 | chr4:92369775-92369776 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs115480739 | chr4:92369776-92369777 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs148311280 | chr4:92369820-92369821 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs545967193 | chr4:92369852-92369853 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs369636292 | chr4:92369900-92369901 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs149839685 | chr4:92369943-92369944 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs547543155 | chr4:92369962-92369963 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs377692605 | chr4:92369963-92369964 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs115620392 | chr4:92370003-92370004 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs559240296 | chr4:92370011-92370012 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs140500873 | chr4:92370058-92370059 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs541926442 | chr4:92370104-92370105 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs371583024 | chr4:92370136-92370137 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs558449036 | chr4:92370144-92370145 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs72880902 | chr4:92370212-92370213 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs550910711 | chr4:92370265-92370266 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs564431776 | chr4:92370268-92370269 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs113483452 | chr4:92370294-92370295 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs79648650 | chr4:92370325-92370326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs547174909 | chr4:92370353-92370354 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs138466104 | chr4:92370370-92370371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs534730878 | chr4:92370376-92370377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs6838823 | chr4:92370384-92370385 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs568090692 | chr4:92370397-92370398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs537039217 | chr4:92370435-92370436 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs551319302 | chr4:92370477-92370478 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs191734496 | chr4:92370505-92370506 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs143031456 | chr4:92370526-92370527 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs373033015 | chr4:92370571-92370572 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs539305566 | chr4:92370592-92370593 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs553151443 | chr4:92370608-92370609 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs561805667 | chr4:92370706-92370707 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs572417962 | chr4:92370765-92370766 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs572938466 | chr4:92370782-92370783 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs150670894 | chr4:92370805-92370806 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs561845738 | chr4:92370873-92370874 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs575276978 | chr4:92371003-92371004 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs541048312 | chr4:92371015-92371016 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs544210776 | chr4:92371025-92371026 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs138868194 | chr4:92371058-92371059 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs62309589 | chr4:92371079-92371080 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs28685630 | chr4:92371156-92371157 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs144492666 | chr4:92371163-92371164 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs560771528 | chr4:92371210-92371211 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs139495091 | chr4:92371212-92371213 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs183570849 | chr4:92371248-92371249 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs74745986 | chr4:92371265-92371266 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Parkinson disease | 20877625 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Obesity | 20622171 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 20164919 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:92369800-92372000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
2 | chr4:92370000-92370600 | Enhancers | NH-A | brain |
3 | chr4:92370000-92370800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
4 | chr4:92370000-92370800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr4:92370200-92370400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr4:92370200-92370600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr4:92370400-92371200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
8 | chr4:92370400-92371600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr4:92370600-92375200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
10 | chr4:92371200-92371400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
11 | chr4:92371400-92375000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
12 | chr4:92372000-92375000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
13 | chr4:92373800-92374200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
14 | chr4:92375000-92375400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
15 | chr4:92375000-92375400 | Bivalent Enhancer | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr4:92375000-92375400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
17 | chr4:92375000-92375800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
18 | chr4:92375200-92375600 | Enhancers | HUES48 Cell Line | embryonic stem cell |